Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David W Murray

Showing results (191-200 of 199) with videos related to

Pageof 20
Sort By:
You have reached the last page of results.This site can display upto 199 results.
Arthritis and Rheumatism|July 9, 2011
The association between hip morphology parameters and nineteen-year risk of end-stage osteoarthritis of the hip: a nested case-control studyAlex S Nicholls, Amit Kiran, Thomas C B Pollard, et al.
The Lancet. Rheumatology|November 21, 2025
Assessing clinical and cost effectiveness of total versus partial knee replacement (TOPKAT): 10-year follow-up of a multicentre, randomised controlled trialDavid J Beard, Loretta J Davies, Jonathan A Cook, et al.
Trials|December 18, 2019
Study of Peri-Articular Anaesthetic for Replacement of the Knee (SPAARK): study protocol for a patient-blinded, randomised controlled superiority trial of liposomal bupivacaineRuth Knight, Lisa Poulton, Louise H Strickland, et al.
Hip International : the Journal of Clinical and Experimental Research on Hip Pathology and Therapy|June 24, 2011
Hip resurfacing and pseudotumourDavid W Murray, George Grammatopoulos, Roger Gundle, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 16, 2016
Mechanistic interrogation of combination bevacizumab/dual PI3K/mTOR inhibitor response in glioblastoma implementing novel MR and PET imaging biomarkersPhilip J O'Halloran, Thomas Viel, David W Murray, et al.
Cancers|December 1, 2020
Targeting the RhoGEF βPIX/COOL-1 in Glioblastoma: Proof of Concept StudiesKate Connor, David W Murray, Monika A Jarzabek, et al.
JAMA Surgery|April 6, 2022
Efficacy of Liposomal Bupivacaine and Bupivacaine Hydrochloride vs Bupivacaine Hydrochloride Alone as a Periarticular Anesthetic for Patients Undergoing Knee Replacement: A Randomized Clinical TrialThomas W Hamilton, Ruth Knight, Jamie R Stokes, et al.
Plos One|January 28, 2017
A Novel Positron Emission Tomography (PET) Approach to Monitor Cardiac Metabolic Pathway Remodeling in Response to Sunitinib MalateAlice C O'Farrell, Rhys Evans, Johanna M U Silvola, et al.
Therapeutic Advances in Medical Oncology|August 7, 2019
Pilot study of bevacizumab in combination with docetaxel and cyclophosphamide as adjuvant treatment for patients with early stage HER-2 negative breast cancer, including analysis of candidate circulating markers of cardiac toxicity: ICORG 08-10 trialGiuseppe Gullo, Alex J Eustace, Alexandra Canonici, et al.
Pageof 20

Showing results (191-200 of 199) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 199 results.
Arthritis and Rheumatism|July 9, 2011
The association between hip morphology parameters and nineteen-year risk of end-stage osteoarthritis of the hip: a nested case-control studyAlex S Nicholls, Amit Kiran, Thomas C B Pollard, et al.
The Lancet. Rheumatology|November 21, 2025
Assessing clinical and cost effectiveness of total versus partial knee replacement (TOPKAT): 10-year follow-up of a multicentre, randomised controlled trialDavid J Beard, Loretta J Davies, Jonathan A Cook, et al.
Trials|December 18, 2019
Study of Peri-Articular Anaesthetic for Replacement of the Knee (SPAARK): study protocol for a patient-blinded, randomised controlled superiority trial of liposomal bupivacaineRuth Knight, Lisa Poulton, Louise H Strickland, et al.
Hip International : the Journal of Clinical and Experimental Research on Hip Pathology and Therapy|June 24, 2011
Hip resurfacing and pseudotumourDavid W Murray, George Grammatopoulos, Roger Gundle, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 16, 2016
Mechanistic interrogation of combination bevacizumab/dual PI3K/mTOR inhibitor response in glioblastoma implementing novel MR and PET imaging biomarkersPhilip J O'Halloran, Thomas Viel, David W Murray, et al.
Cancers|December 1, 2020
Targeting the RhoGEF βPIX/COOL-1 in Glioblastoma: Proof of Concept StudiesKate Connor, David W Murray, Monika A Jarzabek, et al.
JAMA Surgery|April 6, 2022
Efficacy of Liposomal Bupivacaine and Bupivacaine Hydrochloride vs Bupivacaine Hydrochloride Alone as a Periarticular Anesthetic for Patients Undergoing Knee Replacement: A Randomized Clinical TrialThomas W Hamilton, Ruth Knight, Jamie R Stokes, et al.
Plos One|January 28, 2017
A Novel Positron Emission Tomography (PET) Approach to Monitor Cardiac Metabolic Pathway Remodeling in Response to Sunitinib MalateAlice C O'Farrell, Rhys Evans, Johanna M U Silvola, et al.
Therapeutic Advances in Medical Oncology|August 7, 2019
Pilot study of bevacizumab in combination with docetaxel and cyclophosphamide as adjuvant treatment for patients with early stage HER-2 negative breast cancer, including analysis of candidate circulating markers of cardiac toxicity: ICORG 08-10 trialGiuseppe Gullo, Alex J Eustace, Alexandra Canonici, et al.
Pageof 20